HPV-DNA testing will be implemented in five high-burden districts of TN

The Ministry of Health plans to cover 1,24,215 women under the HPV-DNA testing program.

Tamil Nadu is all set to implement HPV-DNA testing for cervical cancer in the five high burden districts of Dharmapuri, Villupuram, Tiruvannamalai, Perambalur and Ariyalur in the first phase. The Ministry of Health plans to cover 1,24,215 women under the HPV-DNA testing programme.

In an order issued recently, the state government has granted permission to the Director of Mission, National Health Mission (NHM), Tamil Nadu, to implement the programme, which was one of the chief minister’s announcements in an assembly earlier this year.

The NHM has sent a proposal to the state government to introduce an HPV-DNA testing program for cervical cancer in women under the Tamil Nadu Cancer Care Mission. According to the Tamil Nadu Cancer Registry Project 2023 report, 87,156 new cancer cases were reported in Tamil Nadu in 2023 – 37,931 among males and 49,225 among females. The projected number of new cancer cases for 2026 is around one million (94,098).

Cervical cancer remains an important cause of morbidity and mortality among women in Tamil Nadu despite being largely preventable through vaccination, effective screening, early identification of precancerous lesions and timely treatment, she said, adding that Tamil Nadu has been introducing screening for three common cancers – breast, cervical and oral – at the institutional level since 2012. Acetic acid. Population screening for common non-communicable diseases and organized cancer screening were also implemented in the state.

HPV-DNA testing provides an objective and highly sensitive method for identifying women at risk for precancer and cervical cancer. It has the advantages of high sensitivity, reproducibility and high negative predictive value. The World Health Organization therefore recommends it as a primary screening method. The WHO Regional Implementation Framework for Cervical Cancer Elimination, emphasizing the 90-70-90 targets, includes screening 70% of women with a high-throughput test by age 35 and again by age 45. Therefore, it is proposed to introduce HPV-DNA testing as a primary screening method to strengthen the existing cervical cancer screening program in Tamil Nadu.

The Mission Director said that the Government of India has sanctioned ₹ 869.50 lakh in the NHM Record of Proceedings 2026-2027 under the State-Specific Initiatives and Innovations category for conducting HPV-DNA testing for cervical cancer in women aged 35 years. The estimated expenditure on testing at an indicative cost of ₹ 700 per test works out to ₹ 8,69,50,500, the order said. The initiative will be extended to other districts gradually subject to the approval of the Government of India.

Published – 17 Nov 2026 19:41 IST